Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma

Background: Second- and third-generation chemotherapy protocols for the treatment of aggressive non-Hodgkin's lymphomas (NHL) have considerable, and age-related, toxic effects. In addition, they do not seem to prolong overall survival in comparison to standard CHOP chemotherapy. In this phase I...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 1998-11, Vol.9 (11), p.1213-1217
Hauptverfasser:	Celsing, F., Widell, S., Merk, K., Bernell, P., Grimfors, G., Hedlund, A., Liliemark, J., Svedmyr, E., Ösby, E., Björkholm, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Chemotherapy CHOP Cyclophosphamide - administration & dosage Doxorubicin - administration & dosage etoposide Etoposide - administration & dosage Female high-grade non-Hodgkin's lymphoma Humans Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - pathology Male Medical sciences Medicin och hälsovetenskap Middle Aged Pharmacology. Drug treatments Prednisone - administration & dosage risk factors Survival Analysis Vincristine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!